Advances in the diagnosis and management of myeloma.
Greipp
P R
PR
Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN 55905.
D000782:Aneuploidy; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis; D001853:Bone Marrow / Q000473:pathology; D016026:Bone Marrow Transplantation; D001859:Bone Neoplasms / Q000175:diagnosis* / Q000628:therapy; D003937:Diagnosis, Differential; D006801:Humans; D007239:Infections / Q000628:therapy; D007378:Interleukins / Q000378:metabolism; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000628:therapy; D008998:Monoclonal Gammopathy of Undetermined Significance / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D009101:Multiple Myeloma / Q000150:complications / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D009367:Neoplasm Staging; D009857:Oncogenes; D010950:Plasma Cells / Q000473:pathology; D010954:Plasmacytoma / Q000175:diagnosis* / Q000628:therapy; D016879:Salvage Therapy; D016176:T-Lymphocyte Subsets / Q000276:immunology / Q000473:pathology
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D007378:Interleukins